Privia Health Group (PRVA) Set to Announce Quarterly Earnings on Thursday

Privia Health Group (NASDAQ:PRVA) will likely be announcing its Q3 2026 results before the market opens on Thursday, November 5th. Analysts expect the company to announce earnings of $0.0905 per share and revenue of $610.72 million for the quarter. Parties can find conference call details on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:00 AM ET.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.07 by $0.12. The business had revenue of $632.63 million for the quarter, compared to the consensus estimate of $597.33 million. Privia Health Group had a net margin of 1.19% and a return on equity of 3.52%. The company’s quarterly revenue was up 21.4% on a year-over-year basis. During the same period last year, the firm earned $0.24 earnings per share. On average, analysts expect Privia Health Group to post $0.27 EPS for the current fiscal year and $0.41 EPS for the next fiscal year.

Privia Health Group Price Performance

Shares of Privia Health Group stock opened at $21.28 on Tuesday. The company’s fifty day simple moving average is $20.88 and its 200-day simple moving average is $22.64. The stock has a market capitalization of $2.72 billion, a PE ratio of 101.34 and a beta of 0.80. Privia Health Group has a 1-year low of $18.92 and a 1-year high of $28.82.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Citigroup restated a “buy” rating on shares of Privia Health Group in a research note on Thursday, July 23rd. Weiss Ratings reiterated a “hold (c)” rating on shares of Privia Health Group in a research report on Tuesday, September 29th. Canaccord Genuity Group set a $32.00 price target on Privia Health Group in a report on Friday, August 7th. Finally, Zacks Research upgraded Privia Health Group from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 5th. Eleven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Privia Health Group currently has an average rating of “Moderate Buy” and a consensus target price of $31.00.

Privia Health Group Company Profile

Privia Health Group, Inc is a physician-enablement company that partners with independent medical practices to support the delivery of coordinated, value-based care. The company provides an integrated platform designed to help physicians manage clinical, administrative and financial functions while maintaining ownership and control of their practices.

Its services include practice management, electronic health record and technology support, revenue-cycle management, payer contracting, population-health analytics, care-management programs and administrative assistance.